Document is current
Any future updates will be listed below
-
Authors
Feng, Summer
Gunawan, Rudy
Passey, Chaitali
Voellinger, Jenna
Polhamus, Daniel
Gerritsen, Arnout
O’Day, Christine
Carret, Anne-Sophie
Soumaoro, Ibrahima
Gupta, Manish
Hanley, William D.
-
Funding
Funding for this research was provided by:
Genmab
Pfizer Inc.
- License Information
-
More Information
Article History
Received: 4 November 2024
Accepted: 26 August 2025
First Online: 3 October 2025
Declarations
:
: All clinical studies were conducted in accordance with good clinical practice guidelines from the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use and the principles of the Declaration of Helsinki. Protocols were approved by relevant regulatory and independent ethics committees.
: SF, AG, IS, and MG report employment and stocks or stock options with Genmab US Inc. RG, JV, CO, and A-SC report employment and stocks or stock options with Pfizer Inc. CP reports employment and stocks or stock options with Genmab US Inc. and grants, consulting fees, and honoraria from Metrum LLC. DP reports employment with Metrum Research Group. WDH reports employment with BeiGene and former employment and stock options with Seagen at the time of study.
